• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number HC100-12
Device Problem Obstruction of Flow (2423)
Patient Problems Congestive Heart Failure (1783); Death (1802); Pulmonary Valve Stenosis (2024); Sepsis (2067); Respiratory Failure (2484); Multiple Organ Failure (3261)
Event Type  Injury  
Event Description
Medtronic received information that a journal article entitled ¿long-term results after correction of persistent truncus arteriosus in 83 patients¿, doi:10.1016/j.Ejcts.2009.12.022, analyzed long-term results after correction/repair of truncus arteriosus in one institution over a 28 year span.Of the 83 patients, repair with reconstruction of the right ventricular to pulmonary artery continuity was performed with a valved conduit in 80 patients, and other methods in the remaining three patients.Within the study time frame 27 deaths occurred, 19 of which were ¿early¿ (mean 4.1 days post-operative) with causes of heart failure (n=11), multiple organ failure (n=3), sepsis (n=2), pulmonary hypertensive crisis (n=2), and sudden death (n=1).The remaining eight deaths occurred ¿late¿ (median 68 days post-operative) with causes of heart failure (n=3), sepsis (n=2), respiratory failure (n=2), and other (n=1).Other non-death adverse events included: 41 re-operations for conduit dysfunction (with a mean of 5.8 years post-operative), 12 trunca l valve replacements, 11 balloon dilatation or stents for conduit obstruction, pulmonary branch stenosis, aortic arch obstruction, orvena cava stenosis.Thirteen medtronic products were implanted in the study population, including hancock bioprosthetic valved conduit (n=12) and contegra pulmonary valved conduit (n=1).None of the observations stated in the article were clearly associated with medtronic products.
 
Manufacturer Narrative
Based on the information available, no conclusion can be drawn with this report.None of the observations stated in the article were clearly associated with medtronic products.(b)(4).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4246067
MDR Text Key20976138
Report Number2025587-2014-00889
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeEZ
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,foreign,literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHC100-12
Device Catalogue NumberHC100-12
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/17/2014
Initial Date FDA Received11/12/2014
Supplement Dates Manufacturer Received10/17/2014
Supplement Dates FDA Received09/15/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-